Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.43 |
| ▸ | FBP1 | P09467 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL141066 | 0.81 | TP53 (0.51) | CYP19A1CA2TP53CYP4F2CYP4A11 | |
| SCHEMBL139610 | 0.81 | CYP19A1 (0.50) | CYP19A1CA2PTGS2PTGS1POLB | |
| SCHEMBL9573442 | 0.81 | CYP19A1 (0.56) | CYP19A1CA2CYP4F2CYP4A11 | |
| SCHEMBL8265344 | 0.80 | CYP19A1 (0.56) | CYP19A1POLBTP53FBP1KMT2A | |
| SCHEMBL141067 | 0.80 | CA2 (0.65) | CA2KMT2AALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL138364 | 0.79 | CA2 (0.64) | CYP19A1CA2KMT2AALDH1A1CYP1A2 | |
| SCHEMBL12040509 | 0.78 | CYP19A1 (0.54) | CYP19A1POLBTP53FBP1KMT2A | |
| SCHEMBL4636718 | 0.78 | CA2 (0.61) | CYP19A1CA2POLBTP53FBP1 | |
| SCHEMBL12039041 | 0.78 | CYP19A1 (0.54) | CYP19A1POLBTP53FBP1KMT2A | |
| SCHEMBL15840358 | 0.77 | CYP19A1 (0.47) | CYP19A1CA2PTGS2PTGS1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120059179-A1 | PALLADIUM-CATALYZED ORTHO-FLUORINATION | The Scripps Research Insitiute (US) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059179-A1 | PALLADIUM-CATALYZED ORTHO-FLUORINATION | POF1B, OCIAD2, ODC1 | CYP19A1 4220/4885CA2 3314/4885PTGS2 4566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.